Particle.news

Download on the App Store

Serena Williams Discloses GLP‑1 Use for 31‑Pound Loss, Becomes Paid Ambassador for Ro

The tennis great frames the medication as a health decision after postpartum struggles, adding momentum to a wider debate over celebrity weight‑loss drug endorsements.

Image
Image
Image
Image

Overview

  • She says she began weekly GLP‑1 injections in early 2024 after stopping breastfeeding and reported losing about 31 pounds over the past year.
  • Williams reports improved blood sugar readings, reduced joint pain and higher energy, and she says she has not experienced side effects.
  • Her disclosure comes with a commercial tie: she is a paid ambassador for telehealth company Ro, where her husband Alexis Ohanian is an investor and board member.
  • Coverage differs on the exact drug, with some outlets naming Zepbound while others note she has not specified a brand.
  • Reaction online has been mixed, with supporters praising her candor and critics questioning the promotion of weight‑loss medications.